Search all trials

Find therapies in clinical trials near you – page 52

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Chronic cutaneous lupus erythematosus+2

Not recruiting

Investigational

Study on the Safety and Effectiveness of Deucravacitinib for Patients with Active Discoid and/or Subacute Cutaneous Lupus Erythematosus

Investigational

France

Participants:18–64 years · 65+ years
Substances:Deucravacitinib

Contact Research Centre

Diffuse large B-cell lymphoma

Not recruiting

Registered drugNo placebo

Study Comparing Axicabtagene Ciloleucel and Standard Treatment for Adults with High-Risk Large B-Cell Lymphoma

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Cyclophosphamide

Contact Research Centre

Dry age-related macular degeneration

Not recruiting

Registered drugNo placebo

Study on the Safety of Avacincaptad Pegol for Patients with Geographic Atrophy Who Completed a Previous Study

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Avacincaptad Pegol

Contact Research Centre

Study of oseltamivir and paracetamol blood levels in critically ill patients with severe influenza requiring mechanical ventilation

Not recruiting

Registered drugNo placebo

Study of oseltamivir and paracetamol blood levels in critically ill patients with severe influenza requiring mechanical ventilation

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Oseltamivir

Contact Research Centre

Secondary progressive multiple sclerosis

Not recruiting

Registered drugNo placebo

Study on Stopping Disease-Modifying Therapies in Inactive Secondary Progressive Multiple Sclerosis Patients Over 50 Using Glatiramer Acetate and Drug Combination

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Azathioprine

Contact Research Centre

Neoplasm

Not recruiting

Registered drugNo placebo

Study of MCLA-129 with Chemotherapy and Osimertinib for Patients with Advanced Non-Small Cell Lung Cancer and Other Solid Tumors

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Hepatocellular carcinoma

Not recruiting

Registered drugNo placebo

Study of lenvatinib treatment benefits in patients with non-resectable liver cancer (hepatocellular carcinoma) who are on liver transplant waiting list after unsuccessful TACE therapy

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Lenvatinib

Contact Research Centre

Sinusitis bacterial+1

Not recruiting

Registered drug

Study on Azithromycin for Treating Chronic Sinusitis in Adults

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Azithromycin

Contact Research Centre

Mucous membrane pemphigoid

Not recruiting

Registered drug

Study on Rituximab and Cyclophosphamide for Patients with Severe Mucous Membrane Pemphigoid

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Glucose

Contact Research Centre

Cystic fibrosis

Not recruiting

Registered drugNo placebo

Long-term safety and efficacy study of elexacaftor/tezacaftor/ivacaftor treatment in people with cystic fibrosis who have non-F508del genetic mutations

Registered drugNo placebo

France

Participants:0–17 years · 18–64 years
Substances:Elexacaftor

Contact Research Centre

Renal failure

Not recruiting

Registered drug

Study Comparing Anakinra and Prednisone for Treating Gout Flare in Patients with Advanced Kidney Disease or Kidney Transplant

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Anakinra

Contact Research Centre

Study on the Effects of Inaxaplin for Adults and Children with APOL1-mediated Proteinuric Kidney Disease

Not recruiting

Investigational

Study on the Effects of Inaxaplin for Adults and Children with APOL1-mediated Proteinuric Kidney Disease

Investigational

France

Participants:0–17 years · 18–64 years
Substances:Inaxaplin

Contact Research Centre

Find therapies in clinical trials near you – page 52

632 trials match your criteria

Chronic cutaneous lupus erythematosus+2

Study on the Safety and Effectiveness of Deucravacitinib for Patients with Active Discoid and/or Subacute Cutaneous Lupus Erythematosus

Diffuse large B-cell lymphoma

Study Comparing Axicabtagene Ciloleucel and Standard Treatment for Adults with High-Risk Large B-Cell Lymphoma

Dry age-related macular degeneration

Study on the Safety of Avacincaptad Pegol for Patients with Geographic Atrophy Who Completed a Previous Study

Study of oseltamivir and paracetamol blood levels in critically ill patients with severe influenza requiring mechanical ventilation

Study of oseltamivir and paracetamol blood levels in critically ill patients with severe influenza requiring mechanical ventilation

Secondary progressive multiple sclerosis

Study on Stopping Disease-Modifying Therapies in Inactive Secondary Progressive Multiple Sclerosis Patients Over 50 Using Glatiramer Acetate and Drug Combination

Neoplasm

Study of MCLA-129 with Chemotherapy and Osimertinib for Patients with Advanced Non-Small Cell Lung Cancer and Other Solid Tumors

Hepatocellular carcinoma

Study of lenvatinib treatment benefits in patients with non-resectable liver cancer (hepatocellular carcinoma) who are on liver transplant waiting list after unsuccessful TACE therapy

Sinusitis bacterial+1

Study on Azithromycin for Treating Chronic Sinusitis in Adults

Mucous membrane pemphigoid

Study on Rituximab and Cyclophosphamide for Patients with Severe Mucous Membrane Pemphigoid

Cystic fibrosis

Long-term safety and efficacy study of elexacaftor/tezacaftor/ivacaftor treatment in people with cystic fibrosis who have non-F508del genetic mutations

Renal failure

Study Comparing Anakinra and Prednisone for Treating Gout Flare in Patients with Advanced Kidney Disease or Kidney Transplant

Study on the Effects of Inaxaplin for Adults and Children with APOL1-mediated Proteinuric Kidney Disease

Study on the Effects of Inaxaplin for Adults and Children with APOL1-mediated Proteinuric Kidney Disease

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.